Skip to main content

AI and Deep learning for Cervical Cancer

Worldwide, the cancer of the cervix (lower portion of the uterus) is the fourth most common cancer. It is also one of the most common causes of deaths due to cancer in women.

Most of my patients that participated in my public health project had wither dementia, Alzheimer's or were frail and sometimes immobile. They would forget their surroundings, spouse name and even getting a regular medical checkup was a challenge. These women, when asked to go for cervical cancer diagnosis, opted out and never showed up. Most of these tests are widely available but are uncomfortable and invasive. Patients are also not keen to go for them unless indicated.

1 in 5 cancer patients across the world experience delay in diagnosis and, it holds true for cervical cancer as well. Cervical cancer is diagnosed more frequently at more advanced stages.

The human papillomavirus (HPV) infection is responsible for 90 percent cases. However, all women infected with this virus will not develop cervical cancer. Of the 150-300 known strains of HPV, 15 are classified as high risk for causing cervical cancer. Other risk factors include a weak immune system as due to HIV infection, malnutrition, having sex from an early age, multiple sex partners, multiple pregnancies, and smoking. Oral contraceptive pill use for a long time has been associated with increased risk of cervical cancer.


Training models (Deep Learning) is just the first of many steps in translating exciting research into a real product. A pathologist’s report after reviewing a patient’s biological tissue samples is often the gold standard in the diagnosis of many diseases. For cancer, in particular, a pathologist’s diagnosis has a profound impact on a patient’s therapy. The reviewing of pathology slides is a very complex task, requiring years of training to gain the expertise and experience to do well. Even with this extensive training, there can be substantial variability in the diagnoses given by different pathologists for the same patient, which can lead to misdiagnoses.

Studying and reviewing all the biological tissues visible on a slide is done by a Pathologist. There can be multiple slides per patient, and at 40X magnification each is more than 10+ gigapixels when digitized. There is a lot of data to cover, and often time is limited.

To address these issues of limited time and diagnostic variability, we are evaluating ways deep learning methods like automated detection algorithm can be applied to digital pathology, helping improve diagnosis and also complement pathologists’ workflow.

In various instances and research on the incidence of cervical cancer and ineffective diagnosis, the following results were found. Patients were either:

1) Adequately screened with normal results
2) Inadequately tested with normal results
3) Unscreened
4) Low-grade abnormality
5) High-grade abnormality

The microstructure of normal tissue is uniform but as the disease progresses the tissue microstructure becomes complex and different. Based on this correlation, Scientists have created a novel light scattering-based method to identify these unique microstructures for detecting cancer progression.

The morphology of healthy and precancerous cervical tissue sites are entirely different, and light that gets scattered from these tissues varies accordingly. It is difficult to evaluate with naked eyes the subtle differences in the scattered light characteristics of the normal and precancerous tissue. The AI (Artificial intelligence) identifies precancerous tissue, and also the stage of progression in minutes.


One such company to mention that we worked with at TechEmerge is MobileODT. MobileODT turns mobile technologies into intelligent visual diagnostic tools that enable any health provider, anywhere in the world, to conduct visual inspections at the level of an expert practitioner.

Cervical cancer diagnoses and deaths are predicted to rise among women over the age of 50. However, deaths from the disease among the young who have been vaccinated are likely to be almost eradicated thanks to school vaccination programs for HPV.

AI and deep learning methods give a promising start to discover the unknown, but there is a lot that still needs to be done. AI Algorithms from some of the most innovative companies across the world are now available for $1/scan and are targetted towards developing countries to improve diagnosis and save time.





Popular posts from this blog

Artificial Intelligence Policy and Governance in HEALTHCARE

  Artificial Intelligence has become the new frontier for digital transformation. Several  #digitalhealth  businesses of today rely on Machine Learning,  #AI  and other such technologies to make healthcare delivery more efficient and comprehensive. However, the efficient and responsible use of AI tools is an ongoing discussion and would mean culture, data management, technology shifts in the industry, and required up-grading and training professionals for better coordination. Hence, with the growing market potential and interest in AI, it is imperative to develop a thoughtthrough regulatory and legal framework on the adoption and use of AI. I have set forward a hypotheses to design a policy framework for AI technologies in my paper- "𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐏𝐨𝐥𝐢𝐜𝐲 – 𝐀 𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞" last year https://lnkd.in/emi3XWwa cited further by "𝐓𝐡𝐞 𝐐𝐮𝐚𝐧𝐝𝐚𝐫𝐲 𝐢𝐧 𝐃𝐚𝐭𝐚 𝐏𝐫𝐨𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐑

Artificial intelligence and Technology for Dentistry

Have you heard of this company  ORCA Dental AI ? ORCA combines clinical expertise with machine learning and AI technologies to create diagnostic reports, treatment plan suggestions and smart clinical predictions. Good to learn about these innovations that benefit every stakeholder in the value chain. Recently,  VideaHealth  raised $20M to Expand AI-Based Diagnostics led by Spark Capital including existing investors Zetta Venture Partners. Among its many benefits to dentists and patients are: – A 31% increase in diagnosis rate for cavities and 26% increase in treatment plan value; – An increase in case acceptance by patients due to second opinions; – Automated workflows accelerate treatment planning and charting; Another company touting AI-powered dental care and practice management is  Overjet , which announced a $42.5 million Series B funding round in December months after it had scored $27 million in Series A funding.  Pearl  provides AI for dental images to assist in diagnosis. It l

Big Data Analytics- The Microscope and Telescope for Pharma/CRO

This article is produced in consultation with Industry experts, and KOLs in India and across the world and especially highlights how “Predictive Analytics algorithms” are poised to provide Useful Analytics to the Pharma industry.   In today’s highly competitive market, it is extremely important for contract research and manufacturers to have access to information that allows them to target the specific segments of the pharmaceutical and biotechnology industry that are looking to outsource the particular services they provide.  Understanding shifts in annual outsourcing budgets and spending can help CROs and CMOs to better position themselves for capturing business, particularly at a time when many – if not all – pharma and biotech companies are looking to cut costs and streamline operations.  As per a recent report by NiceInsights, Analytical Services, Clinical Research, and Clinical Monitoring will be the most demanded services over the next 12 to 18 months. For CROs and CMOs looki